Phil M. Hansbro
Sydney, NSW, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Role of Atypical Chemokines and Chemokine Receptors Pathways in the Pathogenesis of COPD.
Journal: Current medicinal chemistry
Published: February 28, 2020
NLRP1 variant M1184V decreases inflammasome activation in the context of DPP9 inhibition and asthma severity.
Journal: The Journal of allergy and clinical immunology
Published: February 06, 2020
Beyond the obvious: Environmental health implications of polar polycyclic aromatic hydrocarbons.
Journal: Environment international
Published: October 11, 2018
Defining the distinct, intrinsic properties of the novel type I interferon, IFNϵ.
Journal: The Journal of biological chemistry
Published: June 07, 2017
miR-323a-3p regulates lung fibrosis by targeting multiple profibrotic pathways.
Journal: JCI insight
Published: December 13, 2016
Maturation of molybdoenzymes and its influence on the pathogenesis of non-typeable Haemophilus influenzae.
Journal: Frontiers in microbiology
Published: August 08, 2015
Fibulin1C peptide induces cell attachment and extracellular matrix deposition in lung fibroblasts.
Journal: Scientific reports
Published: September 23, 2014
The nucleotide-binding domain, leucine-rich repeat protein 3 inflammasome/IL-1 receptor I axis mediates innate, but not adaptive, immune responses after exposure to particulate matter under 10 μm.
Journal: American journal of respiratory cell and molecular biology
Published: July 03, 2014
Innate immunity to influenza in chronic airways diseases.
Journal: Respirology (Carlton, Vic.)
Published: May 24, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026